TrialInternational journal of clinical oncology2018

A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma.

Yi Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.